Objectives: Migraine is a diseases characterized with severe headaches, with neurological and systemic findings. The purpose of this study is to investigate the prevalence of migraine and to examine whether there is a relationship between atopic disorders, parental history and migraine in asthma patients.

Material And Methods: A total of 288 asthma outpatients, who had the diagnosis by an early or late test of reversibility showing a reversible airway obstruction according to hospital database were included. The presence of headache, atopic symptoms and parental history about asthma, atopic disorders and migraine were asked. The patients with headache were consultated by neurology department and investigated about the presence of migraine. The diagnosis of migraine headache was made if patients fulfilled the International Headache Society (IHS) criteria.

Results: 60.4% of patients described a headache. There were 94 patients (32.6%) with headaches meeting the IHS criteria for migraine. Only 12 patients had migraine with aura. There were atopic symptoms in 86.8% of patients. According to parental history, there were asthma in 47.9%, atopic symptoms in 39.6% and migraine in 22.2% of parents. Patients with atopic symptoms were found to have significantly high rate of headaches (65.3%) "p=0.007". The prevalence of migraine was significantly high in patients with parental atopic symptoms (54%) "p=0.002". Multiple logistic regression analysis identified that gender, parental history of asthma, allergia and migraine, and smoking were independent risk factors for presence of migraine in asthmatics.

Conclusion: There is a high prevalence of migraine headaches in patients with asthma. The coexistence of asthma and headaches may be related with a similar pathophysiological mechanism; parental history, common genetic compounds and smoking may play role in this mechanism. The headaches in asthma patients, atopic symptoms and family history should be questioned, and clinicians should be careful about the presence of migraine.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783079PMC
http://dx.doi.org/10.5152/TurkThoracJ.2017.16008DOI Listing

Publication Analysis

Top Keywords

atopic symptoms
24
parental history
20
migraine
15
prevalence migraine
12
history asthma
12
presence migraine
12
patients
11
asthma
9
presence headache
8
migraine asthma
8

Similar Publications

A 12-year-old spayed female Maltese dog had been receiving oclacitinib, a Janus kinase (JAK) inhibitor, for 7 years to manage chronic pruritus due to atopic dermatitis. During this treatment, the dog was diagnosed with primary hypoadrenocorticism and hypothyroidism based on history, physical examination, and hormonal analysis. This case was initially suspected to be polyglandular autoimmune syndrome (PAS) based on long-term treatment of oclacitinib.

View Article and Find Full Text PDF

Molecular mechanism of crisaborole combined with erythromycin against methicillin-resistant and .

Front Microbiol

February 2025

Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western China, and School of Life Sciences, Ningxia University, Yinchuan, China.

The widespread presence of methicillin-resistant (MRSA) severely threatens convenient therapeutic options in the postantibiotic era. The use of combinations of existing drugs at this stage may be a viable strategy for dealing with complex drug-resistant MRSA infections. An checkerboard MIC (Minimum Inhibitory Concentration) assay, growth curve assay, bactericidal test and scanning electron microscope (SEM) assays were performed to determine whether crisaborole (AN2728), a PDE4 inhibitor for treating atopic dermatitis (AD), produced bactericidal effect with different antibiotics.

View Article and Find Full Text PDF

Mycosis fungoides is the most common cutaneous T-cell lymphoma, with its folliculotropic variant being more aggressive and often misdiagnosed. We present a case of a 38-year-old woman initially diagnosed with severe atopic dermatitis, who later experienced generalized itching, hyperpigmentation, alopecia, and palmoplantar keratoderma over several years. A skin biopsy revealed atypical lymphocytic infiltration with folliculotropism, confirming the diagnosis of folliculotropic mycosis fungoides.

View Article and Find Full Text PDF

Purpose Of Review: It seeks to answer key questions about the molecular and cellular mechanisms underlying Hyper IgE Syndrome (HIES), the genetic mutations responsible, and their contributions to both immunodeficiency and allergic manifestations. Additionally, it aims to explore diagnostic strategies and therapeutic approaches that address these overlapping domains, thereby improving disease management.

Recent Findings: Recent research has identified several pivotal genetic mutations, including those in STAT3, DOCK8, and PGM3, which play critical roles in disrupting immune pathways such as Th17 differentiation and IgE regulation.

View Article and Find Full Text PDF

Novel drug delivery systems in topical treatment of atopic dermatitis.

Naunyn Schmiedebergs Arch Pharmacol

March 2025

SCES's Indira College of Pharmacy, Mumbai Bangalore Highway, Tathawade, Pune, 411033, India.

Atopic dermatitis (AD), also known as eczema, is a chronic skin condition, affecting all ages, characterized by inflammation, itching, dryness, and redness, which can severely impact quality of life. Based on clinical features and symptoms, AD is of several types like contact dermatitis, dyshidrotic eczema, neurodermatitis, seborrheic dermatitis, stasis dermatitis, and nummular eczema. Its pathophysiology involves genetic, environmental, and immunological factors, leading to skin barrier dysfunction.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!